In this video, Yasha S. Modi, MD, discusses end-of-study results for EYP-1901 from EyePoint Pharmaceuticals, a bioerodible, sustained-release intravitreal insert to deliver vorolanib for diabetic ...

More than half of adults and more than one-third of children living in the same home as another adult with prediabetes have ...

The American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society have developed a registry that aims to ...

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

When I attended Franklin & Marshall College in Lancaster, Pennsylvania, I was pre-med mainly for the fun of getting to say, ...

Daily physical activity is effective in reducing risk for heart disease, but a dogmatic 10,000 steps per day goal is not ...

The field of cardiovascular disease prevention has made great strides in the 8 years since publication of the last U.S. blood ...

The likelihood for airway obstruction in a 10-year follow-up visit was heightened among current smokers, former smokers and ...

Wearing orthokeratology contact lenses for 11 years led to a substantial reduction in axial length, with a mean treatment ...

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...

Patients who start dialysis with Medicare Advantage have an 18% lower likelihood of being wait-listed for a kidney transplant ...

Despite increased public awareness and improved treatment for irritable bowel syndrome, symptoms of IBS continue to disrupt ...